Heidelberg, Germany

Konrad Faulstich


Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2003

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Inventive Contributions of Konrad Faulstich

Introduction: Konrad Faulstich, an innovative inventor based in Heidelberg, Germany, has made significant strides in the field of molecular biology and medicine. With 1 patent to his name, Faulstich's work intersects crucial technologies that push the boundaries of genetic research and applications in healthcare.

Latest Patents: Faulstich's patent involves "5'-modified nucleotides and the application thereof in molecular biology and medicine." This invention pertains to 5'-modified nucleotides and nucleic acids that incorporate these nucleotides. It outlines processes for integrating these modified nucleotides into nucleic acids and the subsequent site-specific cleavage of nucleic acids at the 5'-modified monomer building blocks. These methodologies can be utilized for various applications including nucleic acid sequencing, generating nucleic acid libraries, detecting mutations, preparing support-bound nucleic acids, and pharmaceutical purposes.

Career Highlights: Faulstich is currently associated with the European Molecular Biology Laboratory (EMBL), where his cutting-edge research contributes to advancements in molecular biology. His innovative spirit is reflected not only in his patents but also in his collaboration with esteemed professionals in the field.

Collaborations: Throughout his career, Konrad Faulstich has worked closely with Wilhelm Ansorge, a notable figure in molecular biology. Their collaboration has fostered advancements in their respective research areas, further enhancing the scientific community's understanding of molecular interactions and applications.

Conclusion: Konrad Faulstich's contributions to molecular biology through his patented inventions signify the importance of innovation in scientific research. His work exemplifies how novel methodologies can be employed to promote progress in healthcare and genetic research. As he continues his career at EMBL, the impact of his inventions will likely resonate throughout the field for years to come.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…